You are viewing: North America AI in Precision Medicine Market analysis

The North America AI in Precision Medicine Market was valued at $326.41 Million in 2024 and projected to reach to $1718.22 Million by 2029, representing a compound annual growth rate of 31.9%. North America's AI in Precision Medicine market is poised for transformative growth through 2029, driven by increasing healthcare digitalization, rising demand for personalized treatment approaches, and substantial venture capital investments in AI healthcare startups.

North America AI in Precision Medicine Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America AI in Precision Medicine Market Trends and Insights

  • The region is experiencing rapid expansion driven by advanced healthcare infrastructure, significant R&D investments, and widespread adoption of AI-powered diagnostic and treatment solutions.
  • North America's market is projected to grow substantially to $1,718.22 million by 2029, reflecting a compound annual growth rate (CAGR) of 31.9%. The growth trajectory in North America is fueled by increasing demand for personalized medicine, integration of machine learning in clinical workflows, and strong regulatory support for healthcare innovation.
  • North America's leading pharmaceutical and biotech companies are investing heavily in AI-driven drug discovery and genomic analysis platforms.
  • By 2029, North America is expected to maintain its market leadership position, driven by continuous technological advancement and expanding applications across oncology, cardiology, and rare disease diagnostics. North America's competitive advantage stems from its concentration of healthcare technology leaders, robust venture capital ecosystem, and collaborative research institutions.
  • The region's emphasis on data privacy and regulatory compliance further strengthens North America's position as a trusted hub for precision medicine innovation through 2029..

Key Market Statistics

  • CAGR (2024-2029) 31.9% CAGR
  • Market Size, 2024 ~USD 326.41 Million
  • Forecast, 2029 ~USD 1718.22 Million
  • Geography North America

North America AI in Precision Medicine Market Overview

Market Leadership Position :

North America commands the largest share of the global AI in Precision Medicine market, with a 2024 valuation of $326.41 million, reflecting the region's advanced healthcare ecosystem and early AI adoption.

Exceptional Growth Trajectory :

The North American market is projected to reach $1,718.22 million by 2029, representing a robust 31.9% CAGR that outpaces the global average of 30.7%, demonstrating accelerating regional momentum.

Healthcare Infrastructure Advantage :

North America's sophisticated healthcare infrastructure, coupled with substantial R&D investments and regulatory frameworks, creates an ideal environment for AI-powered diagnostic and treatment innovation.

Technology Adoption Leadership :

The region leads in widespread implementation of AI-driven precision medicine solutions, with healthcare providers and pharmaceutical companies actively integrating advanced analytics for personalized patient care.

North America AI in Precision Medicine Market Dynamics

  • The region's mature healthcare system and regulatory clarity create competitive advantages for market participants. Key growth catalysts include expanding electronic health record integration with AI platforms, growing adoption of genomic sequencing combined with machine learning analytics, and increasing reimbursement support for AI-enabled diagnostic tools.
  • Healthcare providers across North America are prioritizing precision medicine investments to improve patient outcomes and reduce treatment costs, positioning the region as the global innovation hub for AI-driven healthcare solutions..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Danaher Corporation

    Analytical And Scientific Instrumentation

    Top Technologies
    • Environmental Testing
    • Gas Chromatography
    • Polymerase Chain Reaction (PCR)
    • Automated Liquid Handling Systems
    • Flow Cytometry
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Shimadzu Corporation
    • Merck KGaA

      Healthcare Analytics

      Top Technologies
      • Machine Learning
      • Natural Language Processing (NLP)
      • Blood Pressure Monitors
      • Computed Tomography (CT)
      • Magnetic Resonance Imaging (MRI)
      Top Companies
      • Oracle Corporation
      • PHILIPS HEALTHCARE
      • Siemens healthineers
      • Zensar Technologies Limited
      • EPIC SYSTEMS CORPORATION

        Key Takeaways

        • North America's AI in Precision Medicine market is valued at $326.41 million in 2024 and is forecast to reach $1,718.22 million by 2029, representing a 31.9% CAGR.
        • North America leads global adoption of AI-powered diagnostic and treatment solutions, supported by advanced healthcare infrastructure and substantial R&D investments.
        • North America's market growth is driven by increasing demand for personalized medicine, machine learning integration in clinical workflows, and strong regulatory support.
        • North America maintains competitive advantage through concentration of healthcare technology leaders, robust venture capital ecosystem, and emphasis on data privacy compliance.

        AI in Precision Medicine Market Report Scope

        Report Metric Details
        Base Year 2024
        Fastest Growing Segment IMAGE ANALYSIS (Tool)
        Forecast Period 2024-2029
        Growth Rate CAGR of 30.7% from 2024 to 2029
        Largest Segment SOFTWARE (Component)
        Market Size Base Year (Billions) ~USD 0.79 (2024)
        Revenue Forecast (Billions) ~USD 3.92 (2029)
        Segments Covered Application, Type, Therapeutic Area, Component, Tool, Deployment, End User, Deployment 2022-2030

        North America AI in Precision Medicine Market Report Segmentation

        8 segment dimensions are covered across the global market.

        By Application

        • Clinical Development
        • De Novo Drug Design
        • Diagnostic & Screening
        • Diagnostics & Screening
        • Drug Discovery
        • Drug Discovery & Development
        • Drug Optimization
        • Drug Repurposing
        • Safety
        • Therapeutics
        • Understanding Diseases

        By Type

        • Deep Learning
        • Disease Diagnosis
        • Disease Progression, Staging & Prognosis
        • Disease Screening
        • Other Machine Learning Types
        • Post Treatment Surveillance & Follow-Up
        • Reinforcement Learning
        • Risk Assessment & Patient Stratification
        • Supervised Learning
        • Therapy Monitoring
        • Therapy Selection & Planning
        • Unsupervised Learning

        By Therapeutic Area

        • Cardiology
        • Hematology
        • Infectious Diseases
        • Neurology
        • Oncology
        • Other Therapeutic Area
        • Other Therapeutic Areas
        • Rare Disease
        • Rare Diseases

        By Component

        • Services
        • Software

        By Tool

        • Computer Vision
        • Context Aware Processing
        • Context-Aware Processing
        • Context-Aware Processing & Computing
        • Image Analysis
        • Machine Learning
        • Natural Language Processing
        • Nlp
        • Other Tools

        By Deployment

        • Cloud-Based
        • Cloud-Based Model
        • Hybrid
        • Hybrid Model
        • On-Premise
        • On-Premise Model

        By End User

        • Healthcare Providers
        • Medical Device/Equipment Companies
        • Other End Users
        • Pharmaceutical & Biotechnology Companies
        • Research Centers, Academic Institutes & Government Organizations
        • Research Centers, Academic Institutes, & Government Organizations

        By Deployment 2022-2030

        • Cloud Based
        • Cloud-Based
        • Hybrid
        • On-Premise

        Target Audience

        • Healthcare Providers & Hospital Systems : Need detailed market insights to evaluate AI precision medicine solutions, understand adoption ROI, and benchmark against peer institutions implementing similar technologies across North America.
        • Pharmaceutical & Biotech Companies : Require market intelligence on AI-driven drug discovery and personalized treatment development opportunities, competitive positioning, and regulatory pathways specific to North American markets.
        • Healthcare Technology Vendors : Seek comprehensive market analysis to identify customer segments, assess competitive threats, refine product strategies, and prioritize North American expansion investments in precision medicine platforms.
        • Investment & Private Equity Firms : Need market sizing, growth projections, and investment opportunity analysis for North American AI healthcare startups and established players in the precision medicine ecosystem.
        • Healthcare Policy & Regulatory Bodies : Require market trend data and adoption metrics to inform reimbursement policies, regulatory frameworks, and healthcare innovation initiatives supporting AI precision medicine in North America.

        North America vs. other regions

        HowNorth America compares to the other 3 regional blocs covered in this market.

        Europe
        ~USD 1185.99 Million · 31.3% wtd CAGR ·
        Asia Pacific
        ~USD 776.17 Million · 27.9% wtd CAGR ·
        Latin America
        ~USD 147.86 Million · 30.1% wtd CAGR ·
        Middle East & Africa
        ~USD 95.36 Million · 28.1% wtd CAGR ·

        Countries within North America - compare and drill down

        Country2025 size (native)
        USUSD 93.87 Million
        CanadaUSD 9.08 Million

        Country market size visualization

        US
        USD 93.87 Million
        Canada
        USD 9.08 Million

        Reasons to Buy this Report

        • Regional Market Dominance Insights : Gain comprehensive understanding of why North America leads globally in AI precision medicine adoption, including competitive landscape analysis, key market players, and regional success factors.
        • Growth Opportunity Identification : Identify high-potential investment and partnership opportunities within North America's rapidly expanding $1.7B market by 2029, with detailed segment analysis and emerging application areas.
        • Strategic Market Positioning : Develop data-driven go-to-market strategies specific to North American healthcare providers, pharmaceutical companies, and technology vendors with localized insights and regulatory considerations.
        • Competitive Intelligence : Access detailed competitive benchmarking for North American market participants, including technology differentiation, pricing strategies, and market share dynamics across key segments.
        • Risk Mitigation & Forecasting : Leverage North America-specific market forecasts and trend analysis to make informed business decisions, anticipate market shifts, and align resource allocation with regional growth trajectories.

        Frequently asked questions

        What is the current market size of AI in Precision Medicine in North America?

        North America's AI in Precision Medicine market is estimated at $326.41 million in 2024 and is projected to grow to $1,718.22 million by 2029.

        What is the expected growth rate for North America's AI in Precision Medicine market?

        North America's AI in Precision Medicine market is expected to grow at a compound annual growth rate (CAGR) of 31.9% from 2024 to 2029.

        What are the primary drivers of AI in Precision Medicine adoption in North America?

        North America's market growth is driven by increasing demand for personalized medicine, integration of machine learning in clinical workflows, strong regulatory support, and significant investments by leading pharmaceutical and biotech companies.

        Which therapeutic areas are experiencing the most growth in North America's AI in Precision Medicine market?

        North America is seeing significant expansion in AI applications across oncology, cardiology, and rare disease diagnostics, with continuous technological advancement enabling new clinical applications.

        What competitive advantages does North America hold in the AI in Precision Medicine market?

        North America benefits from a concentration of healthcare technology leaders, a robust venture capital ecosystem, collaborative research institutions, and strong emphasis on data privacy and regulatory compliance.

        RESEARCH METHODOLOGY

        The study involved significant activities to estimate the current size of the AI in precision medicine market. Exhaustive secondary research was done to collect information on the AI in precision medicine market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the AI in precision medicine market.

        Secondary Research

        This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for the companies offering AI in precision medicine solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases.

        Various secondary sources were referred to in the secondary research process to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of AI in precision medicine vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

        Primary Research

        In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the AI in precision medicine market.

        After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also undertaken to identify the segmentation types, industry trends, competitive landscape of AI in precision medicine solutions offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies.

        In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

        Breakdown of Primary Participants:

        AI in Precision Medicine Market

        Note 1: Others include sales managers, marketing managers, and product managers.

        Note 2: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        Both top-down and bottom-up approaches were used to estimate and validate the total size of the AI in precision medicine market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

        • The key players in the industry and markets have been identified through extensive secondary research.
        • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
        • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
        AI in Precision Medicine Market

        Data Triangulation

        After arriving at the overall market size using the market size estimation processes explained above, the market was split into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

        Market Definition

        The AI in precision medicine market utilises AI technologies such as machine learning and natural language processing to analyse complicated biological and clinical data in order to provide possibly personalised healthcare solutions. It promotes applications such as drug discovery, diagnostics, predictive analytics, and tailored treatment plans by integrating genomics, proteomics, and real-world data using AI capabilities with the goal of improving patient outcomes and accelerating innovation benefits for stakeholders ranging from pharmaceutical companies and healthcare providers to researchers.

        Stakeholders

        • Transfection products manufacturing companies
        • Pharmaceutical & Biopharmaceutical Companies
        • Chemical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations (CROs)
        • Contract Development and Manufacturing Organizations (CDMOs)
        • Research Institutes and Universities 
        • Venture Capitalists & Investors
        • Government Associations

        Report Objectives

        • To define, describe, and forecast the AI in precision medicine market based on application, therapeutic area, component, tools, deployment, end user, and region.
        • To provide detailed information about the major factors (drivers, opportunities, restraints, and challenges) influencing the growth of the market
        • To analyze opportunities for stakeholders by identifying the high-growth segments of the market
        • To forecast the size of the market segments with respect to five main regions: North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
        • To analyze subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market
        • To profile the key players and comprehensively analyze their market sizes and core competencies.
        • To track and analyze competitive developments such as acquisitions, collaborations, agreements, mergers, product launches & updates, partnerships, expansions, and other recent developments in the market globally.

        Get the Full AI in Precision Medicine Market Report

        Full forecast, segment splits, and company analysis for all AI in Precision Medicine Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status